Top Markets
#1 ADO Protocol ADO Protocol +335.18%
#2 GoPlus Security GoPlus Security +42.11%
#3 Starpower Starpower +31.42%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.15%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +17.94%
#7 Nockchain Nockchain +14.81%
#8 DMT-NAT DMT-NAT +14.09%
#9 Provenance Blockchain Provenance Blockchain +12.69%
#10 Euler Euler +12.61%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Eusol Biotech Co.,Ltd. Eusol Biotech Co.,Ltd.

Eusol Biotech Co.,Ltd.

6652
Rank in Stocks #33033
Eusol Biotech Co.,Ltd. is a biopharmaceutical firm primarily dedicated to the... Eusol Biotech Co.,Ltd. is a biopharmaceutical firm primarily dedicated to the discovery and advancement of innovative biotechnological treatments for various sleep-related conditions. Its current development portfolio showcases two key candidates: ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) designed to restore and repair neuronal function; and SM-1, a singular capsule formulation that combines three commercially available sedative medications. The company commenced operations in 1994 and maintains its principal offices in Taipei, Taiwan.
Share Price
$0.06232609
Last synced: 2026-04-09
Market Cap
$8.54M
Change (1 day)
-12.89%
Change (1 year)
-68.75%
Country
TW
Trade Eusol Biotech Co.,Ltd. (6652)

Category

Healthcare
Revenue for Eusol Biotech Co.,Ltd. (6652)
Revenue in Aug 2026 TTM: 0
According to Eusol Biotech Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eusol Biotech Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE